Progyny, Inc. (PGNY)

NASDAQ: PGNY · IEX Real-Time Price · USD
27.79
-0.23 (-0.82%)
At close: Jul 19, 2024, 4:00 PM
27.02
-0.77 (-2.77%)
After-hours: Jul 19, 2024, 7:12 PM EDT
-0.82%
Market Cap 2.65B
Revenue (ttm) 1.11B
Net Income (ttm) 61.26M
Shares Out 95.22M
EPS (ttm) 0.62
PE Ratio 44.82
Forward PE 34.93
Dividend n/a
Ex-Dividend Date n/a
Volume 1,064,592
Open 28.23
Previous Close 28.02
Day's Range 27.51 - 28.32
52-Week Range 23.90 - 44.95
Beta 1.46
Analysts Strong Buy
Price Target 43.57 (+56.78%)
Earnings Date Aug 1, 2024

About PGNY

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various servic... [Read more]

Sector Healthcare
IPO Date Oct 25, 2019
Employees 566
Stock Exchange NASDAQ
Ticker Symbol PGNY
Full Company Profile

Financial Performance

In 2023, Progyny's revenue was $1.09 billion, an increase of 38.34% compared to the previous year's $786.91 million. Earnings were $62.04 million, an increase of 104.35%.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for PGNY stock is "Strong Buy." The 12-month stock price forecast is $43.57, which is an increase of 56.78% from the latest price.

Price Target
$43.57
(56.78% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Assisted Reproductive Technology Market Report 2024-2033: Vitrolife Leads the Competition with 9.8% Share, Followed by Ferring, and Progyny

Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "Assisted Reproductive Technology Global Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. The glob...

9 days ago - GlobeNewsWire

Progyny, Inc. to Host 2024 Inaugural Investor Day

NEW YORK, June 26, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that it will host its inaug...

25 days ago - GlobeNewsWire

Progyny, Inc. Announces Enhanced Global Services with Acquisition of Apryl

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced an expansion of its global ...

27 days ago - GlobeNewsWire

Fertility Pioneer and Kindbody Founder Gina Bartasi Returns as CEO to Lead Company's Next Phase of Growth

Kindbody is the Largest Women-founded, Women-led Fertility Company Serving Employers and Families through its National Clinic Network and Proprietary Technology Platform NEW YORK, June 11, 2024 /PRNew...

5 weeks ago - PRNewsWire

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny'...

6 weeks ago - GlobeNewsWire

Progyny's board approves another $100 million stock buyback

The board of Progyny PGNY, -2.62% has approved a $100 million share-repurchase authorization, its second this year.

2 months ago - Market Watch

Progyny, Inc. Announces Additional Share Repurchase Program

NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors ...

2 months ago - GlobeNewsWire

Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Progyny's executives wi...

2 months ago - GlobeNewsWire

Progyny's stock plunges as demand for IVF treatments drops after Alabama ruling

Shares of Progyny Inc. were headed for a record selloff Friday after the fertility-services company said the Supreme Court of Alabama's February ruling regarding in vitro fertilization seemed to scare...

2 months ago - Market Watch

Progyny, Inc. Announces First Quarter 2024 Results

Early Sales Activity and New Partnerships Provide Strong Start to Selling Season, Affirming Continued Demand for Fertility and Family Building Solutions Early Sales Activity and New Partnerships Provi...

2 months ago - GlobeNewsWire

Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report

NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the ...

3 months ago - GlobeNewsWire

Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care

The organizations will host an event with Canada's leading providers, employers, and fertility advocates to show support for the millions in need of family building care The organizations will host an...

3 months ago - GlobeNewsWire

Jim Cramer lays out his top small-cap healthcare picks

'Mad Money' host Jim Cramer shares his small-cap healthcare stock picks.

Other symbols: ADUSCPRXITGROMI
3 months ago - CNBC Television

Jim Cramer recommends five small-cap health-care stocks

CNBC's Jim Cramer said he thinks it could be a good year for small cap stocks and shared his top picks.

Other symbols: ADUSCPRXITGROMI
3 months ago - CNBC

Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges The ...

3 months ago - GlobeNewsWire

Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny...

4 months ago - GlobeNewsWire

This overlooked corner of women's health could be a $350 billion market opportunity

Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.

Other symbols: PFEVTGNBTMDDARE
4 months ago - CNBC

Progyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny...

4 months ago - GlobeNewsWire

Progyny, Inc. Announces Share Repurchase Program

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, announced today that its Board of Directors...

5 months ago - GlobeNewsWire

Progyny Stock Is Falling After Earnings. What the IVF Ruling Means for It.

Shares of fertility-solutions firm Progyny are in the red on disappointing guidance. The company says the Alabama court ruling on in vitro fertilization won't affect it.

5 months ago - Barrons

Progyny, Inc. Announces Fourth Quarter 2023 Results

Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion ...

5 months ago - GlobeNewsWire

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2023 Results Report

NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the q...

5 months ago - GlobeNewsWire

Vistia Health selects Progyny as its preferred fertility and family building benefits provider

Vistia Health brings Progyny's comprehensive suite of fertility and family building services to its clients PHILADELPHIA , Jan. 17, 2024 /PRNewswire/ -- Vistia Health, a healthcare navigator supportin...

6 months ago - PRNewsWire

Progyny Expands its Leadership Team

Katie Higgins has been named Chief Commercial Officer and Steven Leist has been named Chief Technology Officer Katie Higgins has been named Chief Commercial Officer and Steven Leist has been named Chi...

6 months ago - GlobeNewsWire

Progyny, Inc. to Present at 42nd Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny's Chie...

6 months ago - GlobeNewsWire